SUBSCRIBE

Breaking News on Cosmetics Formulation & Packaging in North AmericaEU editionAPAC edition

Headlines > Market Trends

Palomar receives FDA clearance for acne treatment

14-Apr-2004

Palomar Medical Technologies has announced that it has received clearance from the US Food and Drug Administration (FDA) to market its first laser handpiece for the treatment of acne. According to the American Academy of Dermatology, acne affects more than 80 per cent of the world's population.

The LuxV handpiece attachment - for use with Palomar's family of Lux Pulsed Light systems, including the StarLux, MediLux, and EsteLux system - is Palomar's first handpiece to treat acne.

The LuxV handpiece offers a long-term acne solution by treating the root cause of acne, which is the sebaceous glands. The LuxV emits pulses of intense light that alter the structure and function of the sebaceous glands to reduce acne lesions without the many side effects common to drugs.

"We are extremely pleased to receive the additional FDA clearance for the treatment of acne with the LuxV handpiece. This clearance, combined with the recent addition of the StarLux system, could dramatically increase consumer interest in Palomar's light-based cosmetic technology, and propel us to an even greater market share in this growing worldwide market," said Palomar's CEO Joseph Caruso.

In the past, a combination of over the counter cleansers and prescribed topical medications including topical antibiotics, peroxide compounds and topical retinoids have been traditionally recommended to treat acne.

"The advantage of Palomar's approach to the treatment of acne is that it doesn't involve medication. Use of the LuxV handpiece offers acne sufferers a non-drug, easy and effective alternative without the side effects commonly found with drugs. Patients have been extremely happy with the results and enjoy benefits of long lasting clear skin after just a few treatments," said Christine Dierickx, a dermatologist at the Boom Laser Clinic in Belgium.

Acne treatment is the most rapidly growing therapeutic category in the dermatology sector and in the US alone. More than $1.4 billion annually is spent on anti-acne medication and treatment.

Palomar is a leading researcher and developer of light-based systems for hair removal and other cosmetic treatments. Last year Palomar and the Gillette Company entered into an agreement to complete development and commercialise a patented home-use, light-based hair removal device for women.

Subscribe to our FREE newsletter

Get FREE access to authoritative breaking news, videos, podcasts, webinars and white papers. SUBSCRIBE

Related products

Key Industry Events